dc.contributor.advisor | Stensvåg, Klara | |
dc.contributor.author | Mishchenko, Ekaterina | |
dc.date.accessioned | 2018-02-08T10:19:34Z | |
dc.date.available | 2018-02-08T10:19:34Z | |
dc.date.issued | 2017-01-20 | |
dc.description.abstract | Infectious diseases represent an urgent public health problem globally. Particularly healthcare-associated infections are often complicated by antibiotic resistance and presence of recalcitrant microbial biofilms. On the hunt for effective antibiotics with novel mechanisms of action (MOA), researchers look into largely unexplored natural environments with high biodiversity like the oceans, rich in unique natural compounds. In this project, we evaluated the antibacterial potential of a library of synthetic marine natural product mimics (MNPMs) in collaboration with a PhD project in chemistry, both parts of MabCent CRI, Centre for Research-based Innovation on Marine Bioactivities and Drug Discovery. The MNPM library that included 52 compounds, was tested for antibacterial activity in a multi-step screening workflow. An initial screening against six reference bacterial strains was followed by validation in an expanded screening against panels of clinical isolates. In addition to an overall promising activity against common human pathogens, MNPMs were selectively active in vitro against Gram-positive bacteria. Several MNPMs were active against biofilms of the opportunistic pathogen Staphylococcus epidermidis. MOA studies with some selected MNPMs indicated membrane disruption as their primary killing mechanism in Gram-positive bacteria. This mechanism could also explain the anti-biofilm properties of these compounds. Selected compounds did not induce antibiotic resistance development in a serial passage assay. The ability of MNPMs to eradicate biofilm varied between the biofilms of two different S. epidermidis strains. Furthermore, phenotypic variation of biofilms of S. epidermidis strain RP62A was studied. Overall, MNPM candidates characterized in this work, can be used as the leads for further development of antibacterial agents for treatment of chronic infections, often biofilm-associated. Our interdisciplinary approach and screening workflow has a potential to become a well-fitted platform for lead identification, optimization and MOA studies. | en_US |
dc.description.doctoraltype | dr.philos. | en_US |
dc.description.popularabstract | The world needs new medicines that can fight antibiotic resistant bacterial infections complicated by bacterial biofilms. Novel treatment solutions may be found in nature. In this project, we focused on antibacterial activity of approximately 50 molecules that were made synthetically and mimic variants of marine natural compounds. We used an interdisciplinary workflow with multi-step screening against human pathogenic bacteria and biofilms of Staphylococcus epidermidis to identify promising molecules. Two of the most active compounds killed bacteria primarily by destroying the essential bacterial membrane and did not induce the development of antibiotic resistance. Further, we observed that the type of bacterial biofilm strongly affected its susceptibility, both among different subtypes of S. epidermidis and among individual variants of a single subtype. Molecules characterized in this study are promising “starting points” for further development of antibacterial drugs. | en_US |
dc.description.sponsorship | UiT-The Arctic University of Tromsø (UiT) and the Centre for Research-based Innovation on Marine Bioactivities and Drug Discovery (MabCent- CRI) | en_US |
dc.description | Papers number II, III and IV are not available in Munin:</p>
<p>Paper II: Igumnova, E. M., Mishchenko, E., Haug, T., Blencke, H-M., Sollid, J. U. E., Fredheim, E. G. A., ... Strøm, M. B.: "Design and synthesis of amphipathic sulfonamidobenzamides mimicking small antimicrobial marine natural products and investigation of antimicrobial activity against clinical and multi-resistant isolates, and anti-biofilm activity against Staphylococccus epidermidis" (manuscript).</p>
<p>Paper III: Mishchenko, E. S., Igumnova, E. M., Fredheim, E. G. A., Blencke, H-M., Haug, T., Strøm, M. B., ... Stensvåg, K.: "Antibacterial activities and mechanism of action studies of small Marine Natural Product Mimics (MNPMs), G2 and E23" (manuscript)</p>
<p>Paper IV: Mishchenko, E. S., Igumnova, E. M., Blencke, H-M., Fredheim, E. G. A., Haug, T., Stensvåg, K., ... Sollid, J. U. E. : "Staphylococcus epidermidis RP62A phenotypic variation in anti-biofilm screening" (manuscript).</p> | en_US |
dc.identifier.isbn | 978-82-8266-131-7 | |
dc.identifier.uri | https://hdl.handle.net/10037/12105 | |
dc.language.iso | eng | en_US |
dc.publisher | UiT The Arctic University of Norway | en_US |
dc.publisher | UiT Norges arktiske universitet | en_US |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2017 The Author(s) | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/3.0 | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) | en_US |
dc.subject | VDP::Technology: 500::Biotechnology: 590 | en_US |
dc.subject | Marine bioprospecting | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Medical microbiology: 715 | en_US |
dc.subject | anti-biofilm | en_US |
dc.subject | marine natural product mimics | en_US |
dc.subject | mechanism of action | en_US |
dc.subject | Staphylococcus epidermidis | en_US |
dc.subject | RP62A | en_US |
dc.subject | membrane-active | en_US |
dc.subject | ESBL–CARBA | en_US |
dc.subject | antimicrobial | en_US |
dc.subject | drug discovery | en_US |
dc.subject | antibiotic resistance | en_US |
dc.subject | antibacterial | en_US |
dc.title | Antibacterial and anti-biofilm activity of novel marine natural product mimics | en_US |
dc.type | Doctoral thesis | en_US |
dc.type | Doktorgradsavhandling | en_US |